Treace Medical Concepts, Inc. (TMCI) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $65.00K; Additional Paid in CapitalUSD $351.97M; Treasury Stock, ValueUSD $1.42M.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $65.00K; Additional Paid in CapitalUSD $345.50M; Treasury Stock, ValueUSD $1.39M.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $64.00K; Additional Paid in CapitalUSD $337.37M; Treasury Stock, ValueUSD $1.18M.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $64.00K; Additional Paid in CapitalUSD $329.75M; Treasury Stock, ValueUSD $1.11M.
Treace Medical Concepts, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Treasury Stock, Value USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Treasury Stock, Common, Shares shares | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | Adjustments to Additional Paid in Capital, Warrant Issued USD |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $65.00K | $351.97M | $1.42M | $-52.00K | $-282.83M | $67.74M | 259.67K | 3 month · $6.46M | (m) | (m) |
| 2026-03-31 | $0.00 | $65.00K | $345.50M | $1.39M | $-26.00K | $-266.95M | $77.19M | 248.13K | 3 month · $8.03M | (m) | (m) |
| 2025-12-31 | $0.00 | $64.00K | $337.37M | $1.18M | $72.00K | $-248.99M | $87.33M | 165.51K | 12 month · $33.82M | (m) | (m) |
| 2025-09-30 | $0.00 | $64.00K | $329.75M | $1.11M | $83.00K | $-239.60M | $89.19M | 141.57K | 3 month · $8.00M | (m) | (m) |
| 2025-06-30 | $0.00 | $63.00K | $321.51M | $696.00K | $50.00K | $-223.31M | $97.61M | 77.89K | 3 month · $9.58M | (m) | (m) |
| 2025-03-31 | $0.00 | $63.00K | $311.81M | $682.00K | $57.00K | $-205.91M | $105.34M | 76.00K | 3 month · $8.69M | (m) | (m) |
| 2024-12-31 | $0.00 | $62.00K | $303.00M | $281.00K | $97.00K | $-189.99M | $112.89M | 23.39K | 12 month · $30.60M | (m) | (m) |
| 2024-09-30 | $0.00 | $62.00K | $294.39M | $250.00K | $191.00K | $-189.49M | $104.91M | 19.60K | 3 month · $7.90M | (m) | (m) |
| 2024-06-30 | $0.00 | $62.00K | $286.48M | $250.00K | $-26.00K | $-174.13M | $112.14M | 19.60K | 3 month · $6.74M | (m) | (m) |
| 2024-03-31 | $0.00 | $62.00K | $279.43M | $250.00K | $69.00K | $-152.92M | $126.39M | 19.60K | 3 month · $7.41M | (m) | (m) |
| 2023-12-31 | $0.00 | $62.00K | $271.97M | $13.00K | $163.00K | $-134.25M | $137.94M | 1.22K | 12 month · $17.36M | (m) | (m) |
| 2023-09-30 | $0.00 | $62.00K | $265.91M | (m) | $-148.00K | $-127.97M | $137.86M | (m) | 3 month · $5.19M | (m) | (m) |
| 2023-06-30 | (m) | $62.00K | $260.56M | (m) | $-219.00K | $-110.44M | $149.96M | (m) | 3 month · $3.60M | (m) | (m) |
| 2023-03-31 | $0.00 | $61.00K | $255.79M | (m) | $-56.00K | $-98.17M | $157.62M | (m) | 3 month · $2.69M | (m) | (m) |
| 2022-12-31 | $0.00 | $55.00K | $145.22M | $0.00 | $-27.00K | $-84.72M | $60.53M | 0.00 | 12 month · $8.11M | (m) | (m) |
| 2022-09-30 | $0.00 | $46.00K | $142.46M | (m) | (m) | $-80.31M | $62.20M | (m) | 3 month · $2.27M | (m) | (m) |
| 2022-06-30 | $0.00 | $46.00K | $139.84M | (m) | (m) | $-68.17M | $71.71M | (m) | 3 month · $1.96M | (m) | (m) |
| 2022-03-31 | $0.00 | $46.00K | $137.71M | (m) | (m) | $-50.94M | $86.82M | (m) | 3 month · $1.41M | (m) | (m) |
| 2021-12-31 | $0.00 | $45.00K | $134.93M | (m) | $0.00 | $-41.91M | $93.07M | (m) | 12 month · $3.41M | (m) | (m) |
| 2021-09-30 | (m) | (m) | $132.61M | (m) | (m) | $-35.29M | $97.37M | (m) | 3 month · $839.00K 9 month · $2.12M | (m) | (m) |
| 2021-06-30 | (m) | (m) | $131.73M | (m) | (m) | $-28.87M | $102.91M | (m) | 3 month · $875.00K 6 month · $1.28M | (m) | (m) |
| 2021-04-27 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.30M $2.30M | (m) |
| 2021-03-31 | (m) | (m) | $15.14M | (m) | (m) | $-23.79M | $-684.00K | (m) | 3 month · $402.00K | (m) | (m) |
| 2020-12-31 | (m) | (m) | $14.17M | (m) | (m) | $-21.35M | $776.00K | (m) | 12 month · $919.00K | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | $-2.45M | (m) | 3 month · $125.00K 9 month · $582.00K | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | $79.00K | (m) | 3 month · $248.00K 6 month · $457.00K | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | $1.80M | (m) | 3 month · $209.00K | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $3.16M | (m) | 12 month · $815.00K | (m) | 12 month · $595.00K |
| 2018-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $5.95M | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |